REGN
Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc 13F Holders
REGN Stock Ownership Activity
- # of activities:
- 5
- AVG reported price*:
- $546.85
- Current price*:
- +23.90%($677.55)
5 value investing gurus have made changes to the Regeneron Pharmaceuticals Inc (REGN) position according to the gurus' 2025 Q2 SEC quarterly report(s). REGN has been bought (as a new position) by 2, completely sold out by 1 guru(s), the number of REGN shares has been increased by 2 super investor(s).
Which gurus or hedge funds bought REGN in 2025 Q2?
According to the 2025 Q2 SEC filing(s) Regeneron Pharmaceuticals Inc (REGN) has been bought by 4 gurus / funds: Dodge & Cox Stock Fund (added shares +56.33%), Mason Hawkins - Longleaf Partners (added shares +40.34%), Parnassus Endeavor Fund (new buy) and Michael Burry - Scion Asset Management (new buy).
To see more about who is investing in Regeneron Pharmaceuticals Inc (REGN), please go to the REGN ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.